Pettyjohn Wood & White’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-20,850
Closed -$447K 142
2017
Q2
$447K Sell
20,850
-3,800
-15% -$76.7K 0.17% 96
2017
Q1
$423K Hold
24,650
0.16% 98
2016
Q4
$442K Sell
24,650
-2,400
-9% -$43.5K 0.17% 96
2016
Q3
$563K Buy
27,050
+200
+0.7% +$4.96K 0.27% 76
2016
Q2
$722K Buy
26,850
+600
+2% +$16.5K 0.29% 81
2016
Q1
$711K Sell
26,250
-1,600
-6% -$42.9K 0.29% 79
2015
Q4
$809K Sell
27,850
-200
-0.7% -$5.54K 0.34% 74
2015
Q3
$761K Sell
28,050
-600
-2% -$17K 0.35% 72
2015
Q2
$784K Hold
28,650
0.33% 75
2015
Q1
$765K Buy
28,650
+1,100
+4% +$25.3K 0.32% 80
2014
Q4
$583K Hold
27,550
0.24% 84
2014
Q3
$656K Hold
27,550
0.28% 82
2014
Q2
$636K Hold
27,550
0.28% 83
2014
Q1
$629K Sell
27,550
-12,050
-30% -$257K 0.29% 86
2013
Q4
$732K Sell
39,600
-1,500
-4% -$26.1K 0.43% 73
2013
Q3
$695K Hold
41,100
0.43% 74
2013
Q2
$637K Buy
+41,100
New +$684K 0.4% 75

Other funds holding NVO

Pettyjohn Wood & White's NVO Position: Q3 2017 in Review

Pettyjohn Wood & White sold out of Novo Nordisk (NVO) in Q3 2017, closing a stake of 20,850 shares — an estimated $447K sold.

Pettyjohn Wood & White first reported a position in NVO in Q2 2013 and held it in 17 quarters. The position peaked at $809K in Q4 2015. 491 funds tracked by Wall St. Rank hold NVO as of Q3 2017.

  • Pettyjohn Wood & White reported no remaining Novo Nordisk position as of Q3 2017 after selling out during the quarter.
  • Pettyjohn Wood & White sold 20,850 Novo Nordisk shares in Q3 2017, an estimated $447K.
  • Pettyjohn Wood & White first reported a position in Novo Nordisk in Q2 2013 and held it in 17 quarters.
  • Pettyjohn Wood & White's Novo Nordisk position peaked at $809K in Q4 2015.
  • 491 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2017.

Based on Pettyjohn Wood & White's 13F filing for Q3 2017, filed 13 Nov 2017.